Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Developing a Positive Psychology Intervention to Improve Health Behaviors in Type 2 Diabetes: Qualitative Research
Specific Aim #1 (Qualitative Research): To identify, through qualitative research, deficits
in positive affect and associated barriers to completing health behaviors in type 2 DM
patients.
Hypothesis: Patients will be able to complete the structured interview, providing
information about their own positive emotional states, identifying strategies to enhance
positive emotions, linking the presence of positive emotions to better adherence to
health-related behaviors, and identifying additional barriers to completing such behaviors.
Specific Aim #2 (Creation of intervention): To use the data gathered from qualitative and
quantitative measures to create a positive psychology-based intervention
Hypothesis: Using the information provided in this trial, the investigators will be able to
create an intervention, composed of several positive psychology exercises, that is
well-matched with a diabetic population and is targeted to the enhancement adherence to
health-related behaviors in this population. This intervention will then be ready for next
stage testing.
The investigators are proposing to enroll 31 patients with type 2 DM following an outpatient
visit to the MGH Diabetes Center or during admission to Ellison 9-11 inpatient units (or
sometime in the following 14 days if the participant is not available to complete the
interview after consenting for the study).
For these interviews, the investigators will discuss positive emotional states that patients
have experienced and talk about ways they might increase these states. The investigators
will also touch on health behaviors in which the patient has engaged and whether positive
emotions played a role in completing these behaviors. To enhance the accessibility of this
project, the investigators chose to allow patients to complete interviews over the phone.
Interactions by phone (rather than in-person visits) can allow for patients who are being
discharged from the hospital or have no time to complete the interview during a clinic
visit.
The investigators will also conduct a follow up phone call 3 months post-hospitalization
during which the investigators will collect mood and anxiety data from participants. The
purpose of this data will be to better characterize the population, allowing the
investigators to better customize the intervention for this population.
There are two study visits (the first of which can be broken into two parts if the
participant cannot complete the interview in the hospital after consenting to the study).
The first visit will consist of three brief scales of mood and anxiety (Hospital Anxiety and
Depression Scale, Positive and Negative Affect Schedule, and Life Orientation Test—Revised)
that will take 10 minutes, followed by a 45 minute interview. Participants also will report
their race and ethnicity. The second visit will take place 3 months after the initial visit
and will be conducted over the phone. This second visit will consist of the same three brief
scales of mood and anxiety.
Baseline Data: Baseline information about enrolled subjects will also be obtained from the
patients, care providers, the structured assessments of mood and anxiety symptoms as above,
and the electronic medical record as required for characterization of our population. This
information will include data regarding medical history (history of cardiac illness,
diabetes mellitus, hyperlipidemia, and current smoking), current medical variables
(admission diagnosis if applicable, HbA1c), medications, length of hospital stay if
applicable, and sociodemographic data (age, gender, race/ethnicity, living alone). This
information will help the investigators to ensure that the population the investigators
recruit is a representative population of patients with type 2 DM.
Qualitative Data: Subjects will undergo an open-ended, one-hour structured interview. The
interview will be performed by study staff trained in qualitative research methods by the
study PI, Dr. Huffman, using frameworks from Dr. Huffman's prior work. First, subjects will
be asked open-ended questions about positive emotional/cognitive experiences. Interviewers
will ask about subjects' experience with positive thoughts and feelings recently, and will
attempt to elicit both the frequency/intensity of such experiences and the range of such
states (e.g., elation vs. optimism). Next, subjects will be asked in an open-ended manner
about ideas that they may have to increase the frequency and breadth of their own positive
experiences, and then will be asked their opinion about the potential utility of several
different existing positive psychology exercises. The interviewers will then inquire about
the impact that positive thoughts/feelings may have on our specific diabetes-related health
behaviors of interest.
Follow-up 3 Month Phone Call: Three months after discharge from the hospital, a study RA
will call subjects to repeat the measures of mood and anxiety completed at baseline (HADS,
PANAS, and LOT-R). The investigators will record specific times at enrollment that subjects
would prefer to be called (and not to be called) to reduce intrusion on subjects' lives. The
investigators will also remind subjects of their upcoming call, in case they need to
reschedule. If subjects would rather complete the questions in written form rather than over
the phone, the investigators will send them a written packet at the time of each follow-up.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |